Elanco Animal Health

Elanco Animal Health ELAN Stock

$25.74   -2.092050%
Add to favorites
Exchange
Market Cap
$12.87B
LOW - HIGH [24H]
$25.57 - $26.93
VOLUME [24H]
$5.83M
P/E Ratio
0
Earnings per share
-$0.29
ISIN
US28414H1032
Price   Prediction

Elanco Animal Health Price Chart

Sorry, that's all we've gotfor now...

Elanco Animal Health (ELAN) stock price today is 25.74 USD on NYSE (-2.09% on the day). Updated .

Elanco Animal Health ELAN Financial and Trading Overview

Elanco Animal Health stock price 25.74 USD
Previous Close 26.29 USD
Open 26.22 USD
Bid 25 USD x 80000
Ask 27.98 USD x 10000
Day's Range 25.58 - 26.93 USD
52 Week Range 19.4 - 27.98 USD
Volume 5.83M USD
Avg. Volume 5.3M USD
Market Cap 12.87B USD
Beta (5Y Monthly) 1.717
PE Ratio (TTM) N/A
EPS (TTM) -0.29 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 31.15 USD

ELAN Valuation Measures

Enterprise Value 16.69B USD
Trailing P/E N/A
Forward P/E 19.911966
PEG Ratio (5 yr expected) 4.04
Price/Sales (ttm) 2.499135
Price/Book (mrq) 1.9407375
Enterprise Value/Revenue 3.242
Enterprise Value/EBITDA 15.643

Trading Information

Elanco Animal Health Stock Price History

Beta (5Y Monthly) 1.717
52-Week Change 18.15%
S&P500 52-Week Change 8.67%
52 Week High 27.98 USD
52 Week Low 19.4 USD
50-Day Moving Average 23.58 USD
200-Day Moving Average 23.89 USD

ELAN Share Statistics

Avg. Volume (3 month) 5.3M USD
Avg. Daily Volume (10-Days) 5.89M USD
Shares Outstanding 499.83M
Float 495.7M
Short Ratio 6.92
% Held by Insiders 1.20%
% Held by Institutions 109.98%
Shares Short 32.92M
Short % of Float 10.47%
Short % of Shares Outstanding 6.58%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin -2.85%
Operating Margin (ttm) 7.71%
Gross Margin 56.17%
EBITDA Margin 20.72%

Management Effectiveness

Return on Assets (ttm) 1.84%
Return on Equity (ttm) -2.19%

Income Statement

Revenue (ttm) 5.15B USD
Revenue Per Share (ttm) 10.33 USD
Quarterly Revenue Growth (yoy) 11.30%
Gross Profit (ttm) 2.89B USD
EBITDA 1.07B USD
Net Income Avi to Common (ttm) -147000000 USD
Diluted EPS (ttm) -0.3
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 465M USD
Total Cash Per Share (mrq) 0.93 USD
Total Debt (mrq) 4.02B USD
Total Debt/Equity (mrq) 60.59 USD
Current Ratio (mrq) 2.085
Book Value Per Share (mrq) 13.263

Cash Flow Statement

Operating Cash Flow (ttm) 614M USD
Levered Free Cash Flow (ttm) 685.12M USD

Profile of Elanco Animal Health

Country United States
State IN
City Indianapolis
Address 450 Elanco Circle
ZIP 46221
Phone 877 352 6261
Website https://www.elanco.com
Industry Drug Manufacturers - Specialty & Generic
Sector(s) Healthcare
Full Time Employees 9400

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. It also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, the company offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, it offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and Tru Family trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. The company sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Indianapolis, Indiana.

Q&A For Elanco Animal Health Stock

What is a current ELAN stock price?

Elanco Animal Health ELAN stock price today per share is 25.74 USD.

How to purchase Elanco Animal Health stock?

You can buy ELAN shares on the NYSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Elanco Animal Health?

The stock symbol or ticker of Elanco Animal Health is ELAN.

Which industry does the Elanco Animal Health company belong to?

The Elanco Animal Health industry is Drug Manufacturers - Specialty & Generic.

How many shares does Elanco Animal Health have in circulation?

The max supply of Elanco Animal Health shares is 499.83M.

What is Elanco Animal Health Price to Earnings Ratio (PE Ratio)?

Elanco Animal Health PE Ratio is now.

What was Elanco Animal Health earnings per share over the trailing 12 months (TTM)?

Elanco Animal Health EPS is -0.29 USD over the trailing 12 months.

Which sector does the Elanco Animal Health company belong to?

The Elanco Animal Health sector is Healthcare.

Elanco Animal Health ELAN included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech US Smart Pharmaceuticals NQSSPH US 2214.31 USD —
-0.8
— — 2209.33 USD — 2262.42 USD — — — —
us NYSE Composite Index NYA US 22657.82 USD —
-2.08
— — 22604.5 USD — 23257.45 USD — — — —
us US Tech DM Ex Japan Large Mid Ca NQDMXJPLMAUD US 2100.38 AUD 1467.26 USD
<0.01
— — 2100.38 AUD 1467.26 USD 2100.38 AUD 1467.26 USD — — —
$1.98T
Total marketcap
$121.59B
Total volume
BTC 57.42%   •   ETH 9.67%
Dominance
Select currency